Home Search Abstracts View Session E-mail Abstract Author


Session 153 Poster Abstracts
Lypoatrophy/Lipohypertrophy: Predictors and Interventions
Session Day and Time: Monday, 1-4 pm
Room: Hall B


940    
Changes in Body Composition Attributable to Lamivudine, Stavudine, Zidovudine, and Abacavir in HIV-infected Persons Initiating ART
Judith Shlay*1, S Sharma2, G Bartsch2, G Peng2, C Gibert3, C Grunfeld4, and the CPCRA and INSIGHT.
1Denver CPCRA, Denver Publ Hlth, CO, US; 2Univ of Minnesota, Minneapolis, US; 3Wide-Reaching AIDS Prgm, VAMC and George Washington Univ, Washington, DC, US; and 4VAMC and Univ of California, San Francisco, US

Background:  The long-term effects of individual and combination NRTI use on body composition have not been well defined.

Methods:  In a substudy of a multicenter clinical trial, body composition changes were examined in participants initiating ART with 1of 4 NRTI combinations (stavudine [d4T]+lamivudine [3TC], zidovudine [ZDV]+3TC, abacavir [ABC]+3TC, d4T+didanosine [ddI]) with protease inhibitor (PI), NNRTI, or both. Midarm, midthigh, and waist subcutaneous tissue areas and waist visceral tissue area were assessed at baseline and every 4 months. Rates of change in body composition per year of exposure to combinations of and attributable to the individual NRTI were calculated using 2 multivariate repeated measures regression models: Model 1 used 4 variables with updated cumulative time on each NRTI combination; Model 2 used 5 variables with updated cumulative time on individual NRTI. All models adjusted for updated cumulative time on individual PI, NNRTI, and baseline demographic and clinical parameters.

Results:  Among 373 participants who met analysis criteria, 66 received d4T+3TC, 199 received ZDV+3TC, 54 received ABC+3TC, and 54 received d4T+ddI at study entry. Median follow-up was 4 years. Estimated rates of change per year of exposure are shown in the table. Rates for d4T+3TC and ZDV+3TC for subcutaneous tissue area were less negative than for d4T or ZDV alone. The positive rate of 3TC reduced the significant negative rates of d4T and ZDV. For visceral tissue area the significant increase with 3TC combined with the significant decrease with ABC resulted in a non-significant positive rate for ABC+3TC. The increase in visceral tissue area with 3TC augmented the slightly positive rates of ZDV and d4T significantly.

 

NRTI

Subcutaneous tissue area
 (cm2/yr)(p)

Visceral tissue area
(cm2/yr)(p)

Combination:

Midarm

Midthigh

Waist

Waist

d4T+3TC

–0.92 (0.02)

–2.74 (<0.01)

–2.28 (0.19)

11.68 (<0.01)

ZDV+3TC

–1.45 (<0.01)

–1.97 (<0.01)

–2.20 (0.10)

14.84 (<0.01)

ABC+3TC

0.32 (0.40)

0.46 (0.53)

4.51 (<0.01)

2.59 (0.46)

d4T+ddI

–2.14 (<0.01)

–3.73 (<0.01)

–2.57 (0.19)

2.03 (0.63)

Individual:

 

 

 

 

d4T

–1.81 (<0.01)

–4.38 (<0.01)

–4.76 (<0.01)

0.97 (0.79)

ZDV

–2.47 (<0.01)

–3.69 (<0.01)

–5.74 (<0.01)

0.36 (0.92)

ABC

–0.52 (0.17)

–0.52 (0.58)

1.32 (0.41)

–11.5 (<0.01)

3TC

0.57 (0.20)

1.40 (0.10)

3.26 (0.09)

18.6 (<0.01)

ddI

–0.86 (0.09)

0.52 (0.58)

1.05 (0.62)

–0.56 (0.90)

 

Conclusions:  In this prospective evaluation specific differences were identified in the NRTI effects on body composition both individually and in combination. For subcutaneous tissue area, the presence of 3TC reduced tissue loss associated with d4T and ZDV. For visceral tissue area, when combined with d4T or ZDV, the tissue gain with 3TC remained while reducing the visceral tissue loss associated with ABC. 3TC has a significant effect on body composition.